Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-5565 Tablets in Painful Diabetic Peripheral Neuropathy (China Phase 3)
CTR20191151Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirogabalin in diabetic polyneuropathy (DPN), sponsored by Daiichi Sankyo Co., Ltd.. Started Jun 2019; status: completed.
02
Drugs
mirogabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20191151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191151.